376. Venture: Dennis McWilliams of Santé Ventures

About this episode

Omar Khateeb interviews Dennis McWilliams about early-stage medtech investments and the factors that make companies investable.

In this episode, Omar Khateeb speaks with Dennis McWilliams, Managing Director at Santé Ventures , about what makes a medtech company investable at the early stage.From building Apollo Endosurgery to leading venture investments, Dennis shares how Santé evaluates market size, clinical risk, valuation, and exit potential. He also explains why founders should engage investors early and how disciplined capital strategy shapes outcomes.The episode highlights companies like Farapulse, Laminar, Endogenex, and Sonire Therapeutics , and the role of strategics like Medtronic, Boston Scientific, and Johnson and Johnson in driving acquisitions and growth.A focused look at how medtech capital really moves. This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor…

People in this episode

Host: Omar Khateeb

Guest: Dennis McWilliams

Topics covered

• medtech investment
• venture capital
• startup strategy
• market evaluation
• clinical risk
• founder-investor relations

Keywords

• medtech
• venture capital
• investment strategy
• clinical risk
• market size
• founders
• acquisitions

Mentioned in this episode

Organizations: Santé Ventures, Apollo Endosurgery, Farapulse, Laminar, Endogenex, Sonire Therapeutics, Medtronic, Boston Scientific, Johnson and Johnson

More episodes of State of Medtech

• 389.Should You Quit Your Job for a Startup? The Psychology of Startups vs Corporations Through the Barbarians to Bureaucrats Framework · June 10, 2026 · 29 min
• 388.Market Engineering with Bruce Cleveland of Traction Gap Partners · June 8, 2026 · 1h 12m
• 387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused Strategics · June 3, 2026 · 1h 22m
• 386.Matt Curl of Apollo.io on Why Modern Go To Market Is Becoming the Biggest Competitive Advantage in Business · June 1, 2026 · 59 min
• 385. How to manage your board using the Elephant Slide · May 27, 2026 · 25 min
• 384: Venture: Virginia Giddings of Edwards Lifesciences & Deborah Kilpatrick of Sonder Capital · May 25, 2026 · 1h 18m